Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells
Journal
International Journal of Cardiology
Journal Volume
201
Pages
441-448
Date Issued
2015-10-10
Author(s)
Cheng, Ya-Ting
Yeih, Dong-Feng
Liang, Shu-Man
Chien, Chia-Ying
Yu, Yen-Ling
Jan, Yee-Jee
Kuo, Cheng-Chin
Sung, Li-Ying
Shyue, Song-Kun
Yet, Shaw-Fang
Wu, Kenneth K.
Liou, Jun-Yang
Abstract
Background Rho-associated kinase (ROCK) plays an important role in maintaining embryonic stem (ES) cell pluripotency. To determine whether ROCK is involved in ES cell differentiation into cardiac and hematopoietic lineages, we evaluated the effect of ROCK inhibitors, Y-27632 and fasudil on murine ES and induced pluripotent stem (iPS) cell differentiation. Methods Gene expression levels were determined by real-time PCR, Western blot analysis and immunofluorescent confocal microscopy. Cell transplantation of induced differentiated cells were assessed in vivo in a mouse model (three groups, n = 8/group) of acute myocardial infarction (MI). The cell engraftment was examined by immunohistochemical staining and the outcome was analyzed by echocardiography. Results Cells were cultured in hematopoietic differentiation medium in the presence or absence of ROCK inhibitor and colony formation as well as markers of ES, hematopoietic stem cells (HSC) and cells of cardiac lineages were analyzed. ROCK inhibition resulted in a drastic change in colony morphology accompanied by loss of hematopoietic markers (GATA-1, CD41 and β-Major) and expressed markers of cardiac lineages (GATA-4, Isl-1, Tbx-5, Tbx-20, MLC-2a, MLC-2v, α-MHC, cTnI and cTnT) in murine ES and iPS cells. Fasudil-induced cardiac progenitor (Mesp-1 expressing) cells were infused into a murine MI model. They engrafted into the peri-infarct and infarct regions and preserved left ventricular function. Conclusions These findings provide new insights into the signaling required for ES cell differentiation into hematopoietic as well as cardiac lineages and suggest that ROCK inhibitors are useful in directing iPS cell differentiation into cardiac progenitor cells for cell therapy of cardiovascular diseases. © 2015 Elsevier Ireland Ltd.
Subjects
Cardiac differentiation; Embryonic stem cells; Hematopoietic differentiation; Induced pluripotent stem cells; Rho-associated kinase
Publisher
Elsevier Ireland Ltd
Type
journal article